FBRX
Forte Biosciences Inc
NASDAQ · Biotechnology
$27.59
-1.22 (-4.23%)
Open$28.97
Previous Close$28.81
Day High$31.82
Day Low$27.13
52W High$9.32
52W Low$5.30
Volume—
Avg Volume436.7K
Market Cap345.62M
P/E Ratio28.50
EPS$0.25
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
-71.1% upside
Current
$27.59
$27.59
Target
$7.97
$7.97
$5.39
$7.97 avg
$9.61
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 45.34M | 44.14M | 46.50M |
| Net Income | -10,345,422 | -12,888,213 | -11,210,008 |
| Profit Margin | -22.8% | -29.2% | -24.1% |
| EBITDA | -16,926,895 | -17,594,581 | -16,493,957 |
| Free Cash Flow | -9,838,618 | -11,802,396 | -11,084,789 |
| Rev Growth | -2.5% | -3.2% | -9.7% |
| Debt/Equity | 0.27 | 0.27 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |